Back to search results

Stress Inoculation Training (SIT) for Military Personnel

This study is testing a program called Stress Inoculation Training (SIT) to see if it can help U.S. Navy service members better manage stress and improve their psychological health and resilience. Participants will either receive the SIT program, which includes 2 days of training (8 hours each day) focusing on education and hands-on skills for stressful situations, or they will undergo standard 8-week firefighting training (DCA-FF). Researchers will measure changes in how participants perceive and manage stress and their resilience over about 19 weeks. The study aims to enroll 120 participants. The current recruitment status is unclear.

Study design
This interventional study plans to enroll 120 participants. It compares Stress Inoculation Training (SIT) with standard firefighting training (DCA-FF).
What's involved
Participants will either complete 2 days of Stress Inoculation Training or 8 weeks of standard firefighting training. They will also complete assessments at baseline, about 3, 6, and 11 weeks from baseline, and at the end of the study (around 19 weeks).
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for an average of 19 weeks from baseline, with assessments at various points during this period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06656780

Stress Inoculation Training (SIT): An Evidence-Based, Military Aligned Psychological Performance and Health Sustainment Prototype

Not Yet Recruiting
NAAges 18–65InterventionalPrevention
The University of Texas Health Science Center, Houston
~120 participants
Updated 2025-06-12 on ClinicalTrials.gov
What's tested:SITDCA-FF

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Changes in perceived management of stress as assessed by the Perceived Stress Scale (PSS)
Measured over Baseline, about 3 weeks from baseline, about 6 weeks form baseline, about 11 weeks form baseline, end of study (an average of 19 weeks form baseline)
+1 more outcome measured

Conditions

Stress, Psychological

Explore related trials

Psychological stress

NCT06656780

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • The University of Texas Health Science Center at Houston

    Houston, Texasstudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Sarah Jackson, MFT, PhD · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center, Houston

Who to contact

Sarah Jackson, MFT, PhD
[email protected]
(713) 486-2700
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

US Navy service members on Active Duty or Reserve status
be fluent in English.
be capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form and in this protocol.
have access to a SmartPhone, computer, or tablet to utilize and access the virtual classroom.
agree to undergo psychometric and operational performance testing and participate in ongoing assessments throughout the study duration.
be willing to comply with all study procedures, able to complete all assessments independently, and available for the duration of the study (with reasonable accommodations for military operational demands as they arise).

Exclusion

Active suicidal ideation as assessed by the Investigator at screening or as identified during the study.
Clinically significant history of psychotic disorder, bipolar spectrum disorder, or neurodegenerative disease/dementia as assessed by the Investigator.
Active severe substance abuse as assessed by the investigator in accordance with The Diagnostic and Statistical Manual of Mental Illnesses (DSM-5) Substance Abuse Disorder criteria, or presence of illicit substance abuse.
They are currently undergoing another form of treatment other than supportive therapy (\>2 times per month).
Any other condition/situation that the Investigator believes may interfere with participant safety, study conduct, or interpretation of study data.

What this trial measures

  • Changes in perceived management of stress as assessed by the Perceived Stress Scale (PSS)Baseline, about 3 weeks from baseline, about 6 weeks form baseline, about 11 weeks form baseline, end of study (an average of 19 weeks form baseline)

    This is a 10 item questionnaire and each is scored a 5 -point likert scale from 0(never) to 4(very often) for a score range of 0 to 40, higher total scores indicate higher perceived stress.

  • Change in resilience as assessed by the Connor-Davidson Resilience Scale (CD-RISC)Baseline, about 3 weeks from baseline, about 6 weeks form baseline, about 11 weeks form baseline, end of study (an average of 19 weeks form baseline)

    This is a 25 item questionnaire and each is scored on a 5-point Likert scale ranging from 0 (Not true at all) to 4 (True nearly all the time) for a maximum score of 100 higher score indicating more resilience